Plasmat® Futura
Apheresis machine for extracorporeal elimination of LDL cholesterol in patients with familial hypercholesterolemia, hyperlipoproteinemia (a), hyperfibrinogenemia, transplant vasculopathy.
The Plasmat Futura is a device to perform H.E.L.P. apheresis (heparin-induced extracorporeal LDL precipitation). In this extracorporeal blood purification procedure plasma is initially separated from the blood cells. Adding acetate buffer for acidification and heparin to the plasma LDL (low density lipoprotein)-cholesterol, fibrinogen and lipoprotein(a) is precipitated. The precipitate is removed by filtration and the excess of heparin by specific adssorption from the plasma.
In final bicarbonate dialysis the initial volume and the physiologic pH value of the processed plasma is reconstituted.
Range of Application
The H.E.L.P. apheresis (heparin-induced extracorporeal LDL
precipitation) is suited for the treatment of severe lipometabolic
disorders and rheologically induced diseases with special emphasis
on sudden hearing loss.
Contact
Roland Napierala
Global Business Development Manager
Telephone: +49 (0)5661 71 1265
E-Mail: roland.napierala@bbraun.com
Related products
